Startseite Development and evaluation of an automated hepatitis C virus NS5B sequence-based subtyping assay
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Development and evaluation of an automated hepatitis C virus NS5B sequence-based subtyping assay

  • Diana Koletzki , Stéphanie Dumont , Hans Vermeiren , Bart Fevery , Pieter De Smet und Lieven J. Stuyver
Veröffentlicht/Copyright: 28. Juni 2010
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: Hepatitis C virus (HCV) genotyping and accurate subtype determination is becoming increasingly important to better understand viral evolution, the development of resistance to STAT-C, and possibly even for the treatment and management of chronic HCV-infected patients.

Methods: A subtyping assay based on a 329-bp sequence of the NS5B region, together with an automated subtype interpretation tool was developed. Clinical samples of the six major genotypes were used to assess assay performance characteristics.

Results: The NS5B BLAST-based subtyping assay showed clinical sensitivity for amplification of 89% (n=603 random samples). Assessment of analytical sensitivity of amplification for genotypes 1, 2, 3 and 4 revealed a suitable performance for high viral load samples and decreased only with low viral loads. The results were 100% and 99% accurate at the genotype and subtype level, respectively. A concordance of 97% on genotype level and 62% on subtype level was observed by comparison with subtype results from 5′ non-coding-based assays with a panel of 276 isolates.

Conclusions: The HCV NS5B subtyping assay has been validated for research use. Based on its performance, it is the method of choice in cases where subtype rather than genotype information is needed.

Clin Chem Lab Med 2010;48:1095–102.


Corresponding author: Dr. Diana Koletzki, Virco BVBA, Generaal De Wittelaan L11 B3, 2800 Mechelen, Belgium Phone: +32 15 461 356, Fax: +32 15 461 955,

Received: 2009-8-14
Accepted: 2010-3-11
Published Online: 2010-06-28
Published in Print: 2010-08-01

©2010 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Editorials
  2. Errors in transfusion medicine are not only misidentifications of the recipient, but also pre-analytical and analytical errors
  3. Biochemical and imaging biomarkers: the search for the Holy Grail
  4. Reviews
  5. Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: an update of new CYP21A2 mutations
  6. Potential role of the lipoxygenase derived lipid mediators in atherosclerosis: leukotrienes, lipoxins and resolvins
  7. Minireview
  8. Errors in transfusion: causes and measures to avoid them
  9. Opinion Paper
  10. Improving the harmonisation of the International Normalized Ratio (INR): time to think outside the box?
  11. Genetics and Molecular Diagnostics
  12. Differential contribution of MTHFR C677T variant to the risk of diabetic nephropathy in Lebanese and Bahraini Arabs
  13. Development and evaluation of an automated hepatitis C virus NS5B sequence-based subtyping assay
  14. A novel mutant-enriched liquidchip technology for the qualitative detection of somatic mutations in KRAS gene from both serum and tissue samples
  15. General Clinical Chemistry and Laboratory Medicine
  16. Urine particle evaluation: a comparison between the UF-1000i and quantitative microscopy
  17. Assessment of the Nova StatSensor whole blood point-of-care creatinine analyzer for the measurement of kidney function in screening for chronic kidney disease
  18. Non-invasive fetal RHD genotyping in the first trimester of pregnancy
  19. Cord blood and maternal serum neopterin concentrations in patients with pre-eclampsia
  20. Comparison of cetylpyridinium chloride and cetyltrimethylammonium bromide extractive procedures for quantification and characterization of human urinary glycosaminoglycans
  21. Increased serum concentrations of visfatin and its production by different joint tissues in patients with osteoarthritis
  22. Human immunodeficiency virus-infection induces major changes in high-density lipoprotein particle size distribution and composition: the effect of antiretroviral treatment and disease severity
  23. A less sensitive detector does not necessarily result in a less sensitive method: fast quantification of 13 antiretroviral analytes in plasma with liquid chromatography coupled with tandem mass spectrometry
  24. Reference Values and Biological Variations
  25. Homocysteine in small-for-gestational age and appropriate-for-gestational age preterm neonates from mothers receiving folic acid supplementation
  26. Cancer Diagnostics
  27. Circulating procalcitonin in aseptic carcinoma patients: a specificity study with 18F-fluorodeoxyglucose positron-emission tomography/computed tomography as benchmark
  28. Increased expression of the oncogenic KLF6-SV1 transcript in human glioblastoma
  29. Thyroglobulin measurement in fine-needle aspirates of lymph nodes in patients with differentiated thyroid cancer: a simple definition of the threshold value, with emphasis on potential pitfalls of the method
  30. Infectious Diseses
  31. Evaluation of the BacT/ALERT® 3D system for the implementation of in-house quality control sterility testing at Canadian Blood Services
  32. Letters to the Editor
  33. Should the external quality assessment sample of antinuclear antibodies be of a typical monospecific pattern?
  34. Identification of reduced serum thrombopoietin concentrations in patients with chronic hepatitis C undergoing an interferon therapy
  35. Plasma glycogen phosphorylase BB is associated with pulmonary artery wedge pressure and left ventricle mass index in patients with hypertrophic cardiomyopathy
  36. Target cell formation leading to pseudoleukocytosis in patients with malignant disorders
  37. Controversies on quotient reporting to standardize laboratory results
  38. Abstracts
  39. Fifth Santorini Conference Biologie Prospective 2010
Heruntergeladen am 18.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2010.236/html
Button zum nach oben scrollen